| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |